Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: RedHill Biopharma Limited
Condition: Multiple Myeloma
NCT02757326
ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
Expiration of National Cancer Institute (NCI) funding of the study.